VENETOCLAX | VENETOCLAX | ATC L01XX52
ANTINEOPLASTIC BCL-2 (B-CELL LYMPHOMA 2) INHIBITOR TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH 17P DELETION | ORAL | Cmax 2.42 MICROMOLAR Tmax 6.5 HOUR VD 288 LITER PPB 99.9 PERCENT HT 26 HOUR SOLUBILITY LOW SOLUBILITY IN WATER | BCL-2 PDB 6O0K (CRYSTAL STRUCTURE OF BCL-2 WITH VENETOCLAX) LIGAND CODE = LBM (link to the list of PDB complexes) Download experimental 3D coordinates of LBM with added hydrogens | Apoptosis regulator Bcl-2 UNIPROT P10415 BCL2 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |